← Open Payments lookup

KATHRYN ELLIOTT: Open Payments

NPI 1023109089 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,123 in 68 payments from 16 companies in 2025. Trend: 2023 $1,620 · 2024 $1,030 · 2025 $1,123

Food & beverage: $1,123
CompanyPaymentsAmount
ABBVIE INC.13$229
Lilly USA, LLC16$196
Novo Nordisk Inc9$165
Otsuka America Pharmaceutical, Inc.4$97
AstraZeneca Pharmaceuticals LP6$94
Bayer Healthcare Pharmaceuticals Inc.4$65
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$55
Phathom Pharmaceuticals, Inc.3$54
Astellas Pharma US Inc3$51
Daiichi Sankyo Inc.1$20

Products named: UBRELVY, MOUNJARO, Ozempic, REXULTI, QULIPTA, JARDIANCE, Kerendia, XIFAXAN.

Industry payments across MS — which companies pay providers there.